Changes in Aqueous Concentrations of Various Cytokines After Intravitreal Triamcinolone Versus Bevacizumab for Diabetic Macular Edema

Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

A.P. Adamis, Joan W. Miller, Teresa Bernal et al. · American Journal of Ophthalmology · 1994 · 1.3K citations

Medicine, Endocrinology, Ophthalmology +13

A central role for inflammation in the pathogenesis of diabetic retinopathy

Antonia M. Joussen, Vassiliki Poulaki, Minh Ly Le et al. · The FASEB Journal · 2004 · 1.2K citations

Medicine, Immunology, Ophthalmology +17

The Wisconsin Epidemiologic Study of Diabetic Retinopathy

Ronald Klein, Scot E. Moss, Matthew D. Davis et al. · Ophthalmology · 1984 · 976 citations

Medicine, Endocrinology, Ophthalmology +14

Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy

Robert L. Avery, Joel Pearlman, Dante J. Pieramici et al. · Ophthalmology · 2006 · 802 citations

Medicine, Ophthalmology, Pharmacotherapy +13

Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study

S. Michels, Philip J. Rosenfeld, C PULIAFITO et al. · Ophthalmology · 2005 · 669 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +13